AGIO
Agios Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +11.8% ·
Aktienfluss -0.5% ·
neue Nettopositionen +5.3%
· Formel
Eigentümerfragmentierung: mehr Halter, kleinere aggregierte Beteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +3 | 38.62M | $1.43B | +11 | −8 |
| Q1 2026 | 89 | 0 | 33.63M | $1.14B | +5 | −5 |
| Q4 2025 | 89 | -2 | 38.17M | $1.04B | n/a | −2 |
| Q3 2025 | 19 | +2 | 22.49M | $902.53M | +2 | −1 |
| Q2 2025 | 15 | 0 | 21.02M | $699.20M | n/a | n/a |
| Q1 2025 | 12 | -1 | 9.99M | $292.81M | n/a | −1 |
| Q4 2024 | 13 | +2 | 10.10M | $332.03M | +2 | n/a |
| Q3 2024 | 10 | 0 | 7.27M | $323.20M | n/a | n/a |
| Q2 2024 | 10 | n/a | 7.12M | $306.93M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 5.60M | -1.4% | $224.98M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passiv) | 4.55M | -6.0% | $182.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×13 |
| 3 | Wellington Management ✦ | 2.47M | +485.5% | $99.20M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 4 | State Street Global Advisors ✦ (passiv) | 2.26M | +16.0% | $90.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.66M | -27.1% | $66.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passiv) | 1.42M | +0.8% | $56.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Fisher Asset Management ✦ | 870.14K | -0.8% | $34.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 804.77K | n/a | $32.30M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | Adage Capital Partners ✦ | 800.00K | +1.1% | $32.11M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 491.98K | -54.5% | $19.75M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | Morgan Stanley ✦ | 417.00K | n/a | $16.74M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | D. E. Shaw & Co. ✦ | 367.75K | -38.3% | $14.76M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | JPMorgan Chase ✦ | 366.20K | n/a | $14.70M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 14 | Marshall Wace ✦ | 226.82K | -66.9% | $9.10M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 91.64K | -5.4% | $3.61M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 16 | Two Sigma Investments ✦ | 59.63K | Neu | $2.39M | 0.0% | New | 1 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 20.71K | +11.4% | $831,364 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 18 | Point72 Asset Management ✦ | 6.51K | Neu | $261,190 | 0.0% | New | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 5.05K | -98.3% | $202,667 | 0.0% | ▼ Trim | 6 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Two Sigma Investments | $2.39M | 0.0% |
| Point72 Asset Management | $261,190 | 0.0% |
Ausgestiegen
| Norges Bank | $224,705 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 231 Inhaber, 62.89M Anteile, $1.99B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.